Table 5

AEs leading to discontinuation of pomalidomide or both treatments, according to system organ class (n = 50)

AEs leading to discontinuation of pomalidomide or both treatmentsn (%)
Blood and lymphatic system disorders  
 Anemia 1 (2) 
 Neutropenia 1 (2) 
 Febrile neutropenia 1 (2) 
 Thrombocytopenia 1 (2) 
Musculoskeletal and connective tissue disorders 2 (4) 
 Bone pain 2 (4) 
 Pulmonary embolism 1 (2) 
 Infections 4 (8) 
 Septic shock 3 (6) 
AEs leading to discontinuation of pomalidomide or both treatmentsn (%)
Blood and lymphatic system disorders  
 Anemia 1 (2) 
 Neutropenia 1 (2) 
 Febrile neutropenia 1 (2) 
 Thrombocytopenia 1 (2) 
Musculoskeletal and connective tissue disorders 2 (4) 
 Bone pain 2 (4) 
 Pulmonary embolism 1 (2) 
 Infections 4 (8) 
 Septic shock 3 (6) 

or Create an Account

Close Modal
Close Modal